I. Corporate Profile & Statutory Registry Records
| Official Chinese Name | 香港李時珍(中國)醫藥集團有限公司 | Official English Name | Hong Kong Li Shizhen (China) Pharmaceutical Group Limited |
|---|---|---|---|
| Company Reg No. (CRN) | 3302461 | Business Reg No. (BRN / UBI) | 75552163 HK Unique Business ID · US IRS Form W-8BEN-E Foreign TIN |
| Incorporation Date | 2023-07-26 | Company Category | Private company limited by shares |
| Current Legal Status | Live | Statutory Filing Cycle | 2026-07-26 42d NAR1 Window: Jul 26 – Sep 06 |
| Registered Office Address | ROOM D07, 8/F, BLOCK 2, KAI TAK FACTORY BUILDING STAGE 2, 99 KING FUK STREET, WONG TAI SIN DISTRICT, KOWLOON, HONG KONGKai Tak Factory Building (Stage 2) · 5,370 Co-Located Entities → | ||
|---|---|---|---|
| Significant Controllers (SCR) | Statutorily maintained. To penetrate ultimate beneficial owners (UBO) and holding structures, please apply for a Due Diligence Report. | ||
II. Companies Registry Document Retrieval(Annual Return NAR1 & ND2A Filings)
| Document Name | Action |
|---|---|
745(2) Gazette Notice of Striking Off (Cap. 622 s.745(2)(b)) | |
DOC CR Statutory Filing Document | |
ND4 Notice of Resignation of Company Secretary and Director (English) | |
BRN_REF Reference Document for Business Registration Number as UBI | |
ND2A Notice of Change of Company Secretary and Director (Chinese) | |
NNC1 Incorporation Form (Company Limited by Shares) (Chinese)Founding Shareholders & Directors | |
A&A Articles of Association (A&A) (Chinese) | |
CI Certificate of Incorporation (CI) |
III. Commercial Due Diligence & Regulatory Risk Screening
IV. Corporate Statutory Dossier & Legal Status FAQ
What is the official statutory registration status of Hong Kong Li Shizhen (China) Pharmaceutical Group Limited in Hong Kong?
Yes. Hong Kong Li Shizhen (China) Pharmaceutical Group Limited is a legitimate Hong Kong corporation (Private company limited by shares) duly incorporated under the Companies Ordinance (Cap. 622) on 2023-07-26 (operating for 3 years). According to official registers of the Hong Kong Companies Registry (CR), the entity holds an active statutory standing of [Live / In Operation], possessing independent legal personality and full corporate capacity (Statutory verification: September 2026).
How to verify the Unique Business Identifier (UBI / BRN) and CRN of Hong Kong Li Shizhen (China) Pharmaceutical Group Limited?
The statutory primary identifiers for Hong Kong Li Shizhen (China) Pharmaceutical Group Limited are: 1. Business Registration Number (BRN / Unique Business Identifier UBI): [75552163] (effective from 27 December 2023 under Cap. 310, this 8-digit number serves as the unified corporate identifier and the official Foreign TIN for US IRS Form W-8BEN-E, Line 9b); 2. Company Registration Number (CRN): [3302461] (Cap. 622 incorporation archive number; do not enter the 7-digit CRN as the tax ID). Together, these dual keys uniquely lock the entity in international banking KYC and cross-border contracts.
How to verify the Register of Directors, shareholder equity ratios, and Significant Controllers (SCR) of Hong Kong Li Shizhen (China) Pharmaceutical Group Limited?
Under the Companies Ordinance (Cap. 622) of Hong Kong, incorporated companies do not maintain a single 'legal representative' position; the Board of Directors (Section 643) exercises statutory management authority. Complete current and historical directorships (Form ND2A), registered member shareholdings (Form NAR1 / Section 627), and Ultimate Beneficial Ownership (UBO / SCR under Part 12 Division 2A) are verified through official statutory filing retrieval.
How to retrieve the certified company registry filings and Form NAR1 of Hong Kong Li Shizhen (China) Pharmaceutical Group Limited?
Yes. Statutory indexing confirms that Hong Kong Li Shizhen (China) Pharmaceutical Group Limited has accumulated 8 official filing dossier(s) archived in the Hong Kong Companies Registry (latest statutory filing indexed on 2026-05-29: Gazette Notice of Striking Off (Cap. 622 s.745(2)(b))). Pursuant to Section 662 of the Companies Ordinance (Cap. 622), private companies must deliver an Annual Return (Form NAR1) within 42 days after each incorporation anniversary. Available barcoded dossiers include: latest Annual Return (Form NAR1 - detailing current share capital, registered office, directors, and member shareholdings), Incorporation Form (Form NNC1), Articles of Association, and Change of Company Secretary and Director notices (Form ND2A), each bearing authentic ICRIS electronic barcode verification.
What is the official registered address of Hong Kong Li Shizhen (China) Pharmaceutical Group Limited for legal service of process?
The statutory registered office of Hong Kong Li Shizhen (China) Pharmaceutical Group Limited on official record is situated at: [ROOM D07, 8/F, BLOCK 2, KAI TAK FACTORY BUILDING STAGE 2, 99 KING FUK STREET, WONG TAI SIN DISTRICT, KOWLOON, HONG KONG]. Pursuant to Section 658 of the Companies Ordinance (Cap. 622), every Hong Kong company must maintain a registered office in Hong Kong to which all communications and legal notices may be addressed, and file Form NR1 within 15 days of any address change.
V. Similar Trade Names & Industry Directory
LI SHIZHEN (HK) BIOLOGICAL RESEARCH LIMITED
李時珍(香港)生物研究有限公司
Hong Kong Li Shizhen National Pharmaceutical Limited
香港李時珍國藥股份有限公司
Hong Kong Li Shizhen Chinese Medical Group Co., Limited
香港李時珍國醫集團有限公司
HONG KONG HUILIANMAI NETWORK TECHNOLOGY LIMITED
香港匯聯麥網絡科技有限公司
PALM BIONIC ART TECHNOLOGY LIMITED
掌心仿生藝術科技有限公司
Hong Kong Li Shizhen Overseas Pharmaceutical Co., Limited
香港李時珍海外藥業有限公司